RARE - Ultragenyx Pharmaceutical Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts16161819
Avg. Estimate-1.64-1.59-6.76-5.11
Low Estimate-1.97-2-7.67-7.36
High Estimate-1.49-1.41-6.26-2.34
Year Ago EPS-1.74-1.73-3.97-6.76
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts14141718
Avg. Estimate29.01M34.59M106.39M214.46M
Low Estimate25.6M27.9M95.9M140.8M
High Estimate31.8M39.9M113.42M311.64M
Year Ago Sales11.76M16.26M51.49M106.39M
Sales Growth (year/est)146.60%112.70%106.60%101.60%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-1.96-1.79-1.74-1.7
EPS Actual-1.74-1.73-1.82-1.72
Difference0.220.06-0.08-0.02
Surprise %11.20%3.40%-4.60%-1.20%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-1.64-1.59-6.76-5.11
7 Days Ago-1.64-1.6-6.76-5.12
30 Days Ago-1.67-1.63-6.82-4.94
60 Days Ago-1.67-1.63-6.84-4.94
90 Days Ago-1.69-1.65-6.91-4.9
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days1111
Up Last 30 Days9896
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRAREIndustrySectorS&P 500
Current Qtr.5.70%N/AN/A-0.00
Next Qtr.8.10%N/AN/A0.08
Current Year-70.30%N/AN/A0.03
Next Year24.40%N/AN/A0.10
Next 5 Years (per annum)17.20%N/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A